Xagenic Announces Second Closing of $25.5M Series B

Your Source for Venture Capital and Private Equity Financings

Xagenic Announces Second Closing of $25.5M Series B

Back to Home

2014-07-14

TORONTO, CANADA, Molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, announced today a second closing of its Series B financing.

>> Click here for more funding data on Xagenic

>> To export Xagenic funding data to PDF and Excel, click here

(c) by Massinvestor, Inc. For contact info, please check out our about page.

>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors